Allarity Therapeutics Inc (ALLR) support and resistance · P/E 0.0, rev $25.0K
Allarity Therapeutics Inc (ALLR) is a biotechnology company listed on US.
This page maps Allarity Therapeutics Inc (ALLR) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported ALLR revenue for 2026-06-30 was $25.0K. Net income was -$6.2M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. ALLR currently screens at market cap $15.1M and trailing P/E 0.0.
ALLR currently screens at market cap $15.1M and trailing P/E 0.0. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new ALLR 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the ALLR quote page for the session range and the stock page for the full model.
Not investment advice.